Trial Profile
Randomized, Double-blind, Placebo/Active-controlled, Multi-center, Phase 3 Clinical Trial to Investigate the Safety/Tolerability and Efficacy of YHD001 After Oral Administration in Patients With Acute or Chronic Bronchitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jun 2014
Price :
$35
*
At a glance
- Drugs YHD 001 (Primary) ; Pelargonium sidoides
- Indications Acute bronchitis; Chronic bronchitis
- Focus Therapeutic Use
- Sponsors Yuhan
- 10 Jun 2014 New trial record